Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: Pharmacological and computational approach

BMC Complementary and Alternative Medicine

Volumn 18, Issue 1, 2018, Pages

  Nazir, Nausheen ^a   Zahoor, Muhammad ^a   Nisar, Mohammad ^a   Khan, Imran ^b   Karim, Nasiara ^a   Abdel Halim, Heba ^c   Ali, Akhtar ^d  

^a UNIVERSITY OF MALAKAND   (Pakistan)

^b UNIVERSITY OF SWABI   (Pakistan)

^c UNIVERSITY OF PETRA   (Jordan)

^d Konkuk University   (South Korea)

Author keywords

ABTS; DPPH; HPLC; Molecular docking; Type 2 diabetes

Indexed keywords

ACARBOSE; ACETIC ACID ETHYL ESTER; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BUTANOL; CHLOROFORM; CHOLESTEROL; ELAEAGNUS UMBELLATA EXTRACT; GLIBENCLAMIDE; GLUCOSE; LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; 1,1-DIPHENYL-2-PICRYLHYDRAZYL; 2,2'-AZINO-DI-(3-ETHYLBENZOTHIAZOLINE)-6-SULFONIC ACID; BENZOTHIAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; PHYTOCHEMICAL; PICRIC ACID; SULFONIC ACID DERIVATIVE;

ABTS RADICAL SCAVENGING ASSAY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIABETIC COMPLICATION; DPPH RADICAL SCAVENGING ASSAY; ELAEAGNACEAE; ELAEAGNUS UMBELLATA; ENZYME ACTIVE SITE; HYPERGLYCEMIA; IC50; MOLECULAR DOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; RAT; ANIMAL; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOTHIAZOLES; BIPHENYL COMPOUNDS; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ELAEAGNACEAE; HYPOGLYCEMIC AGENTS; MOLECULAR DOCKING SIMULATION; PHYTOCHEMICALS; PICRATES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SULFONIC ACIDS;

EID: 85058555989     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-018-2381-8     Document Type: Article

References (69)

1. Erejuwa OO, Sulaiman SA, Wahab MS. Honey: a novel antioxidant. Molecules. 2012;17:4400-23.
2. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118-26.
3. Patel DK, Kumar R, Prasad SK, Sairam K, Hemalatha S. Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed. 2011;1(4):316-22.
4. Singh LW. Traditional medicinal plants of Manipur as anti-diabetics. J Med Plants Res. 2011;5(5):677-87.
5. Chandran R, Parimelazhagan T, Shanmugam S, Thankarajan S. Antidiabetic activity of Syzygium calophyllifoliumin Streptozotocin-nicotinamide induced Type-2 diabetic rats. Biomed Pharmacother. 2016;82:547-54.
6. Li-xia Y, Tong-hua L, Zong-tao H, Juan-e L, Li-li W. Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitus. Chin J Integr Med. 2011;17:235-40.
7. Zhang W, Zhao J, Wang J, Pang X, Zhuang X, Zhu X, Qu W. Hypoglycemic effect of aqueous extract of sea buckthorn (Hippophae rhamnoides L.) seed residues in streptozotocin-induced diabetic rats. Phytother Res. 2010;24(2):228-32.
8. Apostolidis E, Kwon IY, Shetty K. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymeslinked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol. 2007;8(1):46-54.
9. Shen XL, Liu H, Xiang H, Qin XM, Du GH, Tian JS. Combining biochemical with 1H NMR-based metabolomics approach unravels the antidiabetic activity of genipin and its possible mechanism. J Pharm Biomed Anal. 2016;129(129):80-9.
10. Danaei G, Finucane M, Lu Y, Singh MG, Cowan JM, Paciorek JC. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.
11. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
12. Monday OM, Uzoma IA. Histological changes and antidiabetic activities of Icacina trichantha tuberextract in beta-cells of alloxan induced diabetic rats. Asian Pac J Trop Biomed. 2013;3(8):628-33.
13. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989;12(8):553-64.
14. Kirtikar KR, Basu BD, Blatter E. Indian medicinal plants book. 2nd ed. Dehra Dun: Bishen Singh Mahendra Pal Singh; 1918.
15. Ahmad DS, Jasra WA, Imtiaz A. Genetic diversity in Pakistani genotypes of Hypophae rhamnoides L. ssp. Turkestanica. Int J Agric Biol Sci. 2003;5(1):10-3.
16. Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Pol Pharm. 2010;67(2):113-8.
17. Ahmad DS, Sabir SM, Juma M, Asad SH. Morphological and biochemical variations in Elaeagnus umbellata Thunb. from mountains of Pakistan. Acta Bot Croat. 2005;64:121-8.
18. Wu MC, Hu HT, Yang L. Proteomic analysis of up-accumulated proteins associated with fruit quality during autumn olive (Elaeagnus umbellata) fruit ripening. J Agric Food Chem. 2011;59(2):577-83.
19. Fodham IM, Clevidenc BA, Wiley ER, Zimmerman RH. Fruit of autumn olive: a rich source of lycopene. HortScience. 2001;36:1136-7.
20. Bhuvaneswari V, Nagini S. Lycopene: a review of its potential as an anticancer agent. Curr Med Chem Anticancer Agents. 2005;5(6):627-35.
21. Perveen R, Suleria HA, Anjum FM, Butt MS, Pasha I, Ahmad S. Tomato (Solanum lycopersicum) carotenoids and lycopenes chemistry; metabolism, absorption, nutrition, and allied health claims - a comprehensive review. Crit Rev Food Sci Nutr. 2015;55(7):919-29.
22. Patel S. Plant genus Elaeagnus: underutilized lycopene and linoleic acid reserve with permaculture potential. Fruits. 2015;70:191-9.
23. Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, Willett W, Hu FB, Sun Q, van Dam RM. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr. 2012;95(4):925-33.
24. Mursu J, Virtanen JK, Tuomainen TP, Nurmi T, Voutilainen S. Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: the Kuopio Ischaemic heart disease risk factor study. Am J Clin Nutr. 2014;99(2):328-33.
25. Zaib A. A reversed phase HPLC-DAD method for the determination of phenolic compounds in plant leaves. Anal Methods. 2015;7:7753-7.
26. Brand-Williams W, Cuvelier M, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28(1):25-30.
27. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26(9-10):1231-7.
28. Ahmad W, Khan I, Khan MA, Ahmad M, Subhan F, Karim N. Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica Linn (aeriel parts) in Streptozotocin induced diabetic rats. J Ethnopharmacol. 2014;151(1):618-23.
29. Miller GL. Use of Dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem. 1959;31:426-8.
30. Ranilla LG, Kwon YI, Apostolidis E, shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and species in Latin America. Bioresour Technol. 2010;101(12):4676-89.
31. Karim N, Curmi J, Gavande N, Johnston GA, Hanrahan JR, Tierney ML, Chebib M. 2′-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(a) receptors. Br J Pharmacol. 2012;165(4):880-96.
32. Sharma B, Salunke R, Balomajumder C, Daniel S, Roy P. Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice. J Ethnopharmacol. 2010;127(2):457-62.
33. Gopalakrishnan V, Iyyam Pillai S, Subramanian SP. Synthesis, spectral characterization, and biochemical evaluation of antidiabetic properties of a new zinc-Diosmin complex studied in high fat diet fed-low dose Streptozotocin induced experimental type 2 diabetes in rats. Biochem Res Int. 2015;2015:11.
34. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig. 2014;5(4):349-58.
35. Bhat M, Kothiwale SK, Tirmale AR, Bhargava SY, Joshi BN. Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model. Evid Based Complement Alternat Med. 2011;2011:561625.
36. Nagappa AN, Thakurdesai PA, VenkatRao N, Singh J. Antidiabetic activity of Terminaliacatappa Linn fruits. J Ethnopharmacol. 2003;88(1):45-50.
37. Shirai T, Hung VS, Morinaka K, Kobayashi T, Ito S. Crystal structure of GH13 alpha-glucosidase GSJ from one of the deepest sea bacteria. Proteins. 2008;73(1):126-33.
38. Maurus R, Begum A, Williams LK, Fredriksen JR, Zhang R, Withers SG, Brayer GD. Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity. Biochemistry. 2008;47(11):3332-44.
39. Kryger G, Silman I, Sussman JL. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica. J Physiol Paris. 1998;92(3-4):191-4.
40. Mobley DL, Gilson MK. Predicting binding free energies: Frontiers and benchmarks. Annu Rev Biophys. 2017;46:531-58.
41. Halgren TA. Identifying and characterizing binding sites and assessing Druggability. J Chem Inf Model. 2009;49(2):377-89.
42. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49(21):6177-96.
43. Oboh G, Ademosun AO, Ayeni PO. Comparative effect of quercetin and rutin on α-amylase, α-glucosidase, and some pro-oxidant-induced lipid peroxidation in rat pancreas. Comp Clin Path. 2014;24:1103-10.
44. Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol (Tokyo). 2006;52(2):149-53.
45. Jhong CH, Riyaphan J, Lin SH, Chia YC, Weng CF. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. Biofactors. 2015;41(4):242-51.
46. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47(7):1750-9.
47. Atmakuri RL, Dathi S. Current trends in herbal medicines. J Pharm Res. 2010;3(1):109-13.
48. Ahmad W, Khan I, Khan MA, Ahmad M, Subhan F, Karim N. Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica Linn (aeriel parts) in Streptozotocin induced diabetic rats. J Ethnopharmacol. 2013;151(1):618-23.
49. Amro B, Aburjai T, Al-Khalil S. Antioxidative and radical scavenging effects of olive cake extract. Fitoterapia. 2002;73:456-61.
50. Cheung LM, Cheung PCK, Ooi VEC. Antioxidant activity and total phenolics of edible mushroom extracts. Food Chem. 2003;81:249-55.
51. Ishaq S, Rathore HA, Sabir SM, Maroof MS. Antioxidant properties of Elaeagnus umbellata berry solvent extracts against lipid peroxidation in mice brain and liver tissues. Food Sci Biotechnol. 2015;24:673-9.
52. Dhital S, Lin AH, Hamaker BR, Gidley MJ, Muniandy A. Mammalian mucosal alpha-glucosidases coordinate with alpha-amylase in the initial starch hydrolysis stage to have a role in starch digestion beyond glucogenesis. PLoS One. 2013;8(4):e62546.
53. Tundis R, Loizzo MR, Menichini F. Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem. 2010;10(4):315-31.
54. Parveen K, Khan R, Siddiqui WA. Antidiabetic effects afforded by Terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats. Int J Diabetes Metab. 2011;19:23-33.
55. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216-26.
56. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49(11):1390-4.
57. Grover JK, Yadav S, Vats V. Medicinal plants of India with antidiabetic potential. J Ethnopharmacol. 2002;81(1):81-100.
58. Kaur G, Kamboj P, Kalia AN. Antidiabetic and anti-hypercholesterolemic effects of aerial parts of Sida cordifolia Linn on Streptozotocin-induced diabetic rats. Indian J Nat Prod Resour. 2011;2:428-34.
59. Srinivasan K, Viswanad B, Asrat L, Kaul LC, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313-20.
60. Maiti R, Das UK, Ghosh D. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol Pharm Bull. 2005;28(7):1172-6.
61. Xu Y, He Z, King GL. Introduction of hyperglycaemia and dyslipidaemia in the pathogenesis of diabetic vascular complications. Curr Diab Rep. 2005;5(2):91-7.
62. Ma Q, Guo Y, Sun L, Zhuang Y. Anti-diabetic effects of phenolic extract from Rambutan peels (Nephelium lappaceum) in high-fat diet and Streptozotocin-induced diabetic mice. Nutrients. 2017;9(8):801.
63. Mestry SN, Dhodi JB, Kumbhar SB, Juvekar AR. Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J Tradit Complement Med. 2016;7(3):273-80.
64. Gushiken LF, Beserra FP, Rozza AL, Bérgamo PL, Bérgamo DA, Pellizzon CH. Chemical and biological aspects of extracts from medicinal plants with antidiabetic effects. Rev Diabet Stud. 2016;13(2-3):96-112.
65. Jameil AN, Khan AF, Arjumand S, Khan FM, Tabassum H. Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients. Int J Clin Exp Pathol. 2014;7(7):4345-9.
66. Or Rashid MH, Haque MZ, Rahman MK, et al. Study on liver dysfunction in type 2 diabetic patients in Bangladesh. Euroasian J Hepatogastroenterol. 2016;6(1):1-4.
67. Wang T, Shankar K, Ronis MJ, Mehendale HM. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J Pharmacol Exp Ther. 2000;294(2):473-9.
68. Almdal TP, Vilstrup H. Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetologia. 1988;31(2):114-8.
69. Jain C, Singh A, Kumar P, Gautam K. Anti-diabetic potential of flavonoids and other crude extracts of stem bark of Mangifera indica Linn: a comparative study. J Sci Innov Res. 2014;3:21-7.